A prospective randomized comparative clinical study to evaluate the safety and efficacy of polyherbal metabolite compounds in type 2 diabetes mellitus Post date July 16, 2024 ← In Vivo validation of the functional role of MicroRNA-4638-3p in breast cancer bone metastasis → Prospecting the Theragnostic Potential of Psycho-Neuro-Endocrinological Perturbation of Gut-Brain-Immune Axis for Improving the Outcomes of Cardiovascular Diseases